Jan B. Egan

41 papers receiving 2.5k citations

Jan B. Egan's Hit Papers

Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma 2014 · 301 citations
3010+4+9Years since publication100200300400500

Peers

Jan B. Egan
Comparison fields: 5 of 87
  • Hematology 942
  • Cancer Research 285
  • Pathology and Forensic Medicine 285
  • Neurology 144
  • Oncology 158
Replace József Zsíros with:
József Zsíros Netherlands
Fernando Ravagnani Italy
Eugenia Haralambieva Germany
Rüediger Liersch Germany
Karin D. Berg United States
Brian Van Ness United States
Robert W. Coupland Canada
TM Grogan United States
Hidenori Haruta Japan
Hans Heinrich Kreipe Germany
Jan B. Egan relative to József Zsíros Netherlands József Zsíros's profile →
Citations per field
00.5×2×4×6×7.2×
József Zsíros · 1×
Citations per year

Countries citing papers authored by Jan B. Egan

Since Specialization
Citations

This map shows the geographic impact of Jan B. Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan B. Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan B. Egan more than expected).

Fields of papers citing papers by Jan B. Egan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan B. Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan B. Egan. The network helps show where Jan B. Egan may publish in the future.

Co-authors

The 25 scholars most cited alongside Jan B. Egan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jan B. Egan Line = papers co-authored together Jan B. Egan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Clonal competition with alternating dominance in multiple myeloma
Hit paper breakdown →
2012550
2 2012343
3
Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma
Hit paper breakdown →
2014301
4 2015185
5 2010151
6 2013143
7 200964
8 201264
9 201757
10 201354
11 201348
12 201546
13 201044
14 201443
15 202343
16 201741
17 202140
18 202139
19 201035
20 201631

About Jan B. Egan

Jan B. Egan is a scholar working on Hematology, Cancer Research, Genetics, Pathology and Forensic Medicine and Surgery, having authored 44 papers that have together received 2.5k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (8 papers), Cancer Genomics and Diagnostics (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Vitamin D Research Studies (4 papers), CNS Lymphoma Diagnosis and Treatment (3 papers), BRCA gene mutations in cancer (3 papers), Virus-based gene therapy research (2 papers) and Genomics and Rare Diseases (2 papers). The work is most often cited by research in Hematology (942 citations), Cancer Research (285 citations), Pathology and Forensic Medicine (285 citations), Neurology (144 citations) and Oncology (158 citations). Jan B. Egan has collaborated with scholars based in United States, Brazil and Germany. Frequent co-authors include A. Keith Stewart, Esteban Braggio, Rafaël Fonseca, Peter Leif Bergsagel, John David Carpten, Jonathan J. Keats, Scott Van Wier, Marta Chesi, Victoria Marie Garbitt and Angela S. Baker. Their work appears in journals such as Blood, PLoS ONE, Oncotarget, The Journal of Steroid Biochemistry and Molecular Biology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact